These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 28155620)

  • 1. NLRP3 Inhibitors as Potential Therapeutic Agents for Treatment of Inflammatory Bowel Disease.
    Perera AP; Kunde D; Eri R
    Curr Pharm Des; 2017; 23(16):2321-2327. PubMed ID: 28155620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective and aggravating effects of Nlrp3 inflammasome activation in IBD models: influence of genetic and environmental factors.
    Bauer C; Duewell P; Lehr HA; Endres S; Schnurr M
    Dig Dis; 2012; 30 Suppl 1():82-90. PubMed ID: 23075874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting NLRP3 Inflammasome in Inflammatory Bowel Disease: Putting out the Fire of Inflammation.
    Shao BZ; Wang SL; Pan P; Yao J; Wu K; Li ZS; Bai Y; Linghu EQ
    Inflammation; 2019 Aug; 42(4):1147-1159. PubMed ID: 30937839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of carboxyamidotriazole on 2,4,6-trinitrobenzene sulfonic acid-induced colitis model is associated with the inhibition of NLRP3 inflammasome and NF-κB activation.
    Du X; Chen W; Wang Y; Chen C; Guo L; Ju R; Li J; Zhang D; Zhu L; Ye C
    Int Immunopharmacol; 2017 Apr; 45():16-25. PubMed ID: 28152446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of NLRP3 inflammasome in inflammatory bowel diseases.
    Tourkochristou E; Aggeletopoulou I; Konstantakis C; Triantos C
    World J Gastroenterol; 2019 Sep; 25(33):4796-4804. PubMed ID: 31543674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic implications of inflammasome in inflammatory bowel disease.
    Khatri V; Kalyanasundaram R
    FASEB J; 2021 May; 35(5):e21439. PubMed ID: 33774860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome.
    Bauer C; Duewell P; Mayer C; Lehr HA; Fitzgerald KA; Dauer M; Tschopp J; Endres S; Latz E; Schnurr M
    Gut; 2010 Sep; 59(9):1192-9. PubMed ID: 20442201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammasome Regulation: Therapeutic Potential for Inflammatory Bowel Disease.
    Xu Q; Zhou X; Strober W; Mao L
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33808793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of NLRP3 Inflammasome in Inflammatory Bowel Disease: Differences Between Crohn's Disease and Ulcerative Colitis.
    Lazaridis LD; Pistiki A; Giamarellos-Bourboulis EJ; Georgitsi M; Damoraki G; Polymeros D; Dimitriadis GD; Triantafyllou K
    Dig Dis Sci; 2017 Sep; 62(9):2348-2356. PubMed ID: 28523573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLRP3: A Promising Therapeutic Target for Inflammatory Bowel Disease.
    Zhang J; Zeng S; Wang P; Chen Y; Zeng C
    Curr Drug Targets; 2023; 24(14):1106-1116. PubMed ID: 37946354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease.
    Chen QL; Yin HR; He QY; Wang Y
    Biomed Pharmacother; 2021 Jun; 138():111442. PubMed ID: 33667791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NLRP3 Inflammasome and Inflammatory Bowel Disease.
    Zhen Y; Zhang H
    Front Immunol; 2019; 10():276. PubMed ID: 30873162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethylamine N-oxide prime NLRP3 inflammasome via inhibiting ATG16L1-induced autophagy in colonic epithelial cells.
    Yue C; Yang X; Li J; Chen X; Zhao X; Chen Y; Wen Y
    Biochem Biophys Res Commun; 2017 Aug; 490(2):541-551. PubMed ID: 28629999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-(2-Oxo-2-phenylethylidene)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (compound 1), a novel potent Nrf2/ARE inducer, protects against DSS-induced colitis via inhibiting NLRP3 inflammasome.
    Wang Y; Wang H; Qian C; Tang J; Zhou W; Liu X; You Q; Hu R
    Biochem Pharmacol; 2016 Feb; 101():71-86. PubMed ID: 26588861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does NLRP3 Inflammasome and Aryl Hydrocarbon Receptor Play an Interlinked Role in Bowel Inflammation and Colitis-Associated Colorectal Cancer?
    Ngui IQH; Perera AP; Eri R
    Molecules; 2020 May; 25(10):. PubMed ID: 32456012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation.
    Liu W; Guo W; Hang N; Yang Y; Wu X; Shen Y; Cao J; Sun Y; Xu Q
    Oncotarget; 2016 May; 7(21):30536-49. PubMed ID: 27105502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological functions of NLRP3 inflammasome: A therapeutic target in inflammatory bowel disease.
    Song Y; Zhao Y; Ma Y; Wang Z; Rong L; Wang B; Zhang N
    Cytokine Growth Factor Rev; 2021 Aug; 60():61-75. PubMed ID: 33773897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics alleviate inflammatory bowel disease in mice by regulating intestinal microorganisms-bile acid-NLRP3 inflammasome pathway.
    Liu Z; Wang H
    Acta Biochim Pol; 2021 Oct; 68(4):687-693. PubMed ID: 34648252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huaier aqueous extract protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NLRP3 inflammasome activation.
    Wang L; Yu Z; Wei C; Zhang L; Song H; Chen B; Yang Q
    Oncotarget; 2017 May; 8(20):32937-32945. PubMed ID: 28380426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.